These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31559906)

  • 1. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Mixture Model With Cure Rate Applied to Breast Cancer Data.
    Gallardo DI; Brandão M; Leão J; Bourguignon M; Calsavara V
    Biom J; 2024 Sep; 66(6):e202300257. PubMed ID: 39104134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stochastic EM algorithm for generalized exponential cure rate model and an empirical study.
    Davies K; Pal S; Siddiqua JA
    J Appl Stat; 2021; 48(12):2112-2135. PubMed ID: 35706615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Expectation Maximization algorithm for fitting the generalized odds-rate model to interval censored data.
    Zhou J; Zhang J; Lu W
    Stat Med; 2017 Mar; 36(7):1157-1171. PubMed ID: 28004414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change point detection in Cox proportional hazards mixture cure model.
    Wang B; Li J; Wang X
    Stat Methods Med Res; 2021 Feb; 30(2):440-457. PubMed ID: 32970523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flexible family of transformation cure rate models.
    Koutras MV; Milienos FS
    Stat Med; 2017 Jul; 36(16):2559-2575. PubMed ID: 28417477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A semiparametric mixture model approach for regression analysis of partly interval-censored data with a cured subgroup.
    Sun L; Li S; Wang L; Song X
    Stat Methods Med Res; 2021 Aug; 30(8):1890-1903. PubMed ID: 34197261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A semiparametric isotonic regression model for skewed distributions with application to DNA-RNA-protein analysis.
    Wang C; Yuan A; Cope L; Qin J
    Biometrics; 2022 Dec; 78(4):1464-1474. PubMed ID: 34492116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EM algorithm for the additive risk mixture cure model with interval-censored data.
    Wang X; Wang Z
    Lifetime Data Anal; 2021 Jan; 27(1):91-130. PubMed ID: 33001344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new survival model with surviving fraction: An application to colorectal cancer data.
    Barriga GD; Cancho VG; Garibay DV; Cordeiro GM; Ortega EM
    Stat Methods Med Res; 2019 Sep; 28(9):2665-2680. PubMed ID: 29984625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flexible cure rate model with dependent censoring and a known cure threshold.
    Bernhardt PW
    Stat Med; 2016 Nov; 35(25):4607-4623. PubMed ID: 27311808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.